| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/28/2001 | CN1324361A Aluminoxane synthesis employing reduced amount of trialkylaluminium compound |
| 11/28/2001 | CN1324258A Aglyco products and method of use |
| 11/28/2001 | CN1324257A Vaporizing device for administering sterile medication |
| 11/28/2001 | CN1324251A Method of stimulating prosaposin receptor activity |
| 11/28/2001 | CN1324250A Method for treating or preventing viral infections and associated diseases |
| 11/28/2001 | CN1324246A Method for enhancing wound healing |
| 11/28/2001 | CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 11/28/2001 | CN1324244A Methods for treating sepsis |
| 11/28/2001 | CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins |
| 11/28/2001 | CN1324242A Novel NEUROPILIN/growth factor binding and use thereof |
| 11/28/2001 | CN1324241A Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues |
| 11/28/2001 | CN1324237A Method for improving pharmacokinetics of tipranavir |
| 11/28/2001 | CN1324212A Method for treating or preventing viral infections and associated diseases |
| 11/28/2001 | CN1323901A New polypeptide-DNA topoisomerase I-12 and polynucleotides for coding same |
| 11/28/2001 | CN1323899A New polypeptide-human phosphatidase 16 and polynucleotides for coding same |
| 11/28/2001 | CN1323897A New polypeptide-human ubiquitin C terminal hydrolase 9 and polynucleotides for coding same |
| 11/28/2001 | CN1323896A New polypeptide-human RNA uncoiling enzyme 12 and polynucleotides for coding same |
| 11/28/2001 | CN1323895A New polypeptide-N-acetylgalactosamine transferase-28 and polynucleotides for coding same |
| 11/28/2001 | CN1323892A New polypeptide-human aldehyde/ketone reductase 9.2 and polynucleotides for coding same |
| 11/28/2001 | CN1323890A New polypeptide-human aldehyde/ketone reductase 9.9 and polynucleotides for coding same |
| 11/28/2001 | CN1323889A New polypeptide-human sailer transposase 11 and polynucleotides for coding same |
| 11/28/2001 | CN1323836A New polypeptide-human zinc finger protein 11 and polynucleotides for coding same |
| 11/28/2001 | CN1323834A New polypeptide-human ATp dependent uncoiling enzyme protein 10 and polynucleotides for coding same |
| 11/28/2001 | CN1323828A New polypeptide-human zinc finger protein 12 and polynucleotides for coding same |
| 11/28/2001 | CN1323827A New polypeptide-human transcriptional activation protein subunit 14 and polynucleotides for coding same |
| 11/28/2001 | CN1323826A New polypeptide-human S4 ribosomal protein 10 and polynucleotides for coding same |
| 11/28/2001 | CN1323825A New polypeptide-human clathrin light chain 9 and polynucleotides for coding same |
| 11/28/2001 | CN1323824A New polypeptide-human uteroglobin 9 and polynucleotides for coding same |
| 11/28/2001 | CN1323823A New polypeptide-human beta-microtubulin folding accessory factor C-9 and polynucleotides for coding same |
| 11/28/2001 | CN1323821A New polypeptide-human zinc finger protein 38 and polynucleotides for coding same |
| 11/28/2001 | CN1323818A New polypeptide-human tumor suppressor factor 14 and polynucleotides for coding same |
| 11/28/2001 | CN1323817A New polypeptide-zinc finger protein SCAN subfamily protein 57 and polynucleotides for coding same |
| 11/28/2001 | CN1323813A New polypeptide-neural syndesis ion channel related protein 11 and polynucleotides for coding same |
| 11/28/2001 | CN1323809A New polypeptide-human uteroglobin 12 and polynucleotide for coding same |
| 11/28/2001 | CN1323806A New polypeptide-human neural cell adhesion protein 31 and polynucleotides for coding same |
| 11/28/2001 | CN1323804A New polypeptide-human ribosome SII protein 12 and polynucleotides for coding same |
| 11/28/2001 | CN1323803A New human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 11/28/2001 | CN1323802A New human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 11/28/2001 | CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses |
| 11/28/2001 | CN1075387C Antitumor agent potentiator comprising IL-6 antagonist |
| 11/27/2001 | US6324479 Methods of determining protein activity levels using gene expression profiles |
| 11/27/2001 | US6323335 Nucleotide sequences coding cell proliferation and differentiation polypeptide; for use in controlling cell proliferation and differentiation; for treating cancer |
| 11/27/2001 | US6323334 Nucleic acid molecules encoding a 103 gene product and uses therefor |
| 11/27/2001 | US6323333 Mouse EDG1 |
| 11/27/2001 | US6323331 Beclin-related nucleic acid molecules, and uses thereof |
| 11/27/2001 | US6323330 Protein C16 and C16N or genes encoding the same |
| 11/27/2001 | US6323329 Nucleic acid sequences of genes encoding high mobility group proteins |
| 11/27/2001 | US6323326 Method of solubilizing, purifying, and refolding protein |
| 11/27/2001 | US6323324 Test kits for detecting the presence of C-terminal hGPIIb fragments |
| 11/27/2001 | US6323321 Monoclonal antibody which binds to an antigen on the megakaryocytic cell for use as diagnostic tool |
| 11/27/2001 | US6323320 Acellular red blood cell substitute |
| 11/27/2001 | US6323319 Method of making hydrolyzed collagen type II |
| 11/27/2001 | US6323318 Human protein kinases hYAK3-2 |
| 11/27/2001 | US6323317 Therapeutic and diagnostics proteins comprising a SOCS box |
| 11/27/2001 | US6323313 Genetically engineered binding protein for use in diagnosis, detection and treatment of vascular system thrombosis |
| 11/27/2001 | US6323312 Cyclic CRF antagonist peptides |
| 11/27/2001 | US6323311 Synthesis of insulin derivatives |
| 11/27/2001 | US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity |
| 11/27/2001 | US6323232 Combination therapy for osteoporosis |
| 11/27/2001 | US6323185 Anti-viral guanosine-rich oligonucleotides and method of treating HIV |
| 11/27/2001 | US6323184 Arteriovenous and venous graft treatments: methods and compositions |
| 11/27/2001 | US6323181 Antitumor agents |
| 11/27/2001 | US6323180 Protease inhibitors; inhibit replication of hepatitis c virus |
| 11/27/2001 | US6323179 Chicken GNRH analogs and uses thereof in regulation of fertility and pregnancy |
| 11/27/2001 | US6323178 Beta-lipotropin methods |
| 11/27/2001 | US6323176 Cyclic peptide antifungal agents |
| 11/27/2001 | US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome |
| 11/27/2001 | US6323029 Therapeutic, diagnostic, and research applications for the modulation of glycogen synthase kinase 3 beta expression |
| 11/27/2001 | US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses |
| 11/27/2001 | US6323027 Common gamma chain monoclonal antibody blocking agents |
| 11/27/2001 | US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases |
| 11/27/2001 | US6323020 Neutralization-sensitive epitopes of Cryptosporidium parvum |
| 11/27/2001 | US6323019 Design of novel highly efficient HIV based packaging systems for gene therapy |
| 11/27/2001 | US6323016 Nucleotide sequences coding tyrosine kinase; for diagnosis and treatment of inflammation, cancer, arteriosclerosis, and psoriasis |
| 11/27/2001 | US6323006 Recombinant human beta-CIS interferon |
| 11/27/2001 | US6323000 To identify compounds that interact with it |
| 11/27/2001 | US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds |
| 11/27/2001 | US6322996 Reacting a physiologically active protein with an amino group donor or alkylamine-containing polysaccharide in presence of transglutaminase, thereby modifying protein by forming an amido linkage between carboxyamide group of glutamine residue |
| 11/27/2001 | US6322990 Methods of identifying agents that block the interaction of a BAP protein with a signaling partner |
| 11/27/2001 | US6322982 Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase |
| 11/27/2001 | US6322978 Repeat polymorphism in the frataxin gene and uses therefore |
| 11/27/2001 | US6322976 Compositions and methods of disease diagnosis and therapy |
| 11/27/2001 | US6322972 Detecting suppressors of ligand binding; transform cells, propagate cells, expose to modulator, compare expression of reporter genes in presence and absence of compound, decrease in expression indicates modulators |
| 11/27/2001 | US6322965 Chimera antigen peptide |
| 11/27/2001 | US6322964 Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies |
| 11/27/2001 | US6322826 High protein |
| 11/27/2001 | US6322805 Amphiphilic block polymer having units of polyethers and polylactones |
| 11/27/2001 | US6322804 Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products |
| 11/27/2001 | US6322797 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same |
| 11/27/2001 | US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 11/27/2001 | US6322791 Haemopoietic growth factor antagonists and uses therefor |
| 11/27/2001 | US6322790 Treatment of primary and metastatic noeplastic diseases and infectious diseases; administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule |
| 11/27/2001 | US6322786 Growing saos-2 cells, removing culture medium with serum, washing, incubating, collecting culture medium without serum, filtering, obtaining desired retentate |
| 11/27/2001 | US6322784 Glucocorticoid, a compound which stimulates camp production and compound which upregulates peroxisome proliferator activated receptor .gamma. expression |
| 11/27/2001 | US6322779 Purified, unglycosylated endotoxin and pyrogen-free, high specific biological activity; two monomer structure |
| 11/27/2001 | CA2199941C Synthetic antibiotics |
| 11/27/2001 | CA2145866C Human calcitonin receptor |
| 11/27/2001 | CA2083286C Recombinant fibrinogenases, preparation and use thereof |
| 11/27/2001 | CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 11/27/2001 | CA2021912C Erythropoietin (epo) peptides and antibodies directed against these |